Company:  SCICLONE PHARMACEUTICALS ... (SCLN)
Form Type:  8-K
Filing Date:  5/16/2013 
CIK:  0000880771 
Address:  950 TOWER LANE
SUITE 900
 
City, State, Zip:  FOSTER CITY, California 94404-2125 
Telephone:  650-358-3456 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$4.76  
Change: 
0.09 (1.93%)  
Trade Time: 
Apr 24  
Market Cap: 
$247.32M
Description of Business
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) is a United States (�US�)-headquartered, China-focused, specialty pharmaceutical company with a substantial commercial business and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders. We are focused on continuing to grow our revenue and profitability in the future. Our business and corporate strategy is focused primarily on the People�s Republic of China (�China�) where we have built a solid reputation and established a strong brand through many years of experience marketing our lead product, ZADAXIN (thymalfasin). In addition, we have an established product promotion business model with large pharmaceutical partners and we are focused on establishing profitability in all of these collaborations. We believe our sales and marketing strengths position us to benefit from the long-term expansion of the pharmaceutical market in China.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01 Entry into a Material Definitive Agreement.
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition.
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.01. Notice of Delisting or Failure to Satisfy a ...
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits
    SIGNATURE
    Exhibit Index
  EXHIBIT 99.1
  EXHIBIT 99.2
BROKERAGE PARTNERS